-transparent.png){kind=logo}
OBJECTIVE Comparison of two cyclophosphamide (CPA) treatment regimens in chronic glomerulonephritis (CGN) patients: oral daily CPA versus intravenous CPA pulses (IV-CPA) MATERIALS AND METHODS: 31 nephrotic patients entered the trial: 12, 16 and 3 with membraneous, mesangial proliferative and mesangiocapillary CGN, respectively. The patients were randomized into two groups. 13 patients of group 1 received oral CPA (1.5-2.0 mg/kg/day for 6 months, while 18 patients of group 2 received IV-CPA pulses (20 mg/kg/monthly, at least 6 pulses) combined with oral prednisolone (40-6-mg/day during 1.5 mo with subsequent tapering). At entry, no statistical differences (p > 0.05) were found between groups 1 and 2 by age, gender, duration of the renal disease, serum creatinine levels, frequency of arterial hypertension. Mean duration of follow-up was 27.6 and 22.6 mo (p > 0.05) for group 1 and 2, respectively. RESULTS After 6 months of follow-up there was no difference in the rate of complete and partial remission between the groups (69 and 83% for group 1 and 2, respectively). The rate of renal function deterioration was also similar. Side effects occurred 3 times more frequently in group 1 than group 2. The mean cumulative course dose of CPA per 1 patient in group 1 was 35.6 g, in group 2--5.6 g. CONCLUSIONS The effectiveness of methods was similar irrespective of CGN morphological form, but in spite of similar rates of remission of nephrotic syndrome, pulse CPA is preferable being more safe as to possible complications.
T N Krasnova, and
E M Shilov, and
I E Tareeva, and
N B Gordovskaia, and
O N Lavrova, and
N G Miroshnichenko, and
O V Troepol'skaia, and
L V Ivanova, and
A A Ivanov
August 2001,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
T N Krasnova, and
E M Shilov, and
I E Tareeva, and
N B Gordovskaia, and
O N Lavrova, and
N G Miroshnichenko, and
O V Troepol'skaia, and
L V Ivanova, and
A A Ivanov
December 1993,
Vnitrni lekarstvi,
T N Krasnova, and
E M Shilov, and
I E Tareeva, and
N B Gordovskaia, and
O N Lavrova, and
N G Miroshnichenko, and
O V Troepol'skaia, and
L V Ivanova, and
A A Ivanov
January 2002,
Terapevticheskii arkhiv,
T N Krasnova, and
E M Shilov, and
I E Tareeva, and
N B Gordovskaia, and
O N Lavrova, and
N G Miroshnichenko, and
O V Troepol'skaia, and
L V Ivanova, and
A A Ivanov
January 2004,
Terapevticheskii arkhiv,
T N Krasnova, and
E M Shilov, and
I E Tareeva, and
N B Gordovskaia, and
O N Lavrova, and
N G Miroshnichenko, and
O V Troepol'skaia, and
L V Ivanova, and
A A Ivanov
September 1951,
Archives of pediatrics,
T N Krasnova, and
E M Shilov, and
I E Tareeva, and
N B Gordovskaia, and
O N Lavrova, and
N G Miroshnichenko, and
O V Troepol'skaia, and
L V Ivanova, and
A A Ivanov
March 1976,
Ceskoslovenska pediatrie,
T N Krasnova, and
E M Shilov, and
I E Tareeva, and
N B Gordovskaia, and
O N Lavrova, and
N G Miroshnichenko, and
O V Troepol'skaia, and
L V Ivanova, and
A A Ivanov
December 1961,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
T N Krasnova, and
E M Shilov, and
I E Tareeva, and
N B Gordovskaia, and
O N Lavrova, and
N G Miroshnichenko, and
O V Troepol'skaia, and
L V Ivanova, and
A A Ivanov
February 1991,
Vrachebnoe delo,
T N Krasnova, and
E M Shilov, and
I E Tareeva, and
N B Gordovskaia, and
O N Lavrova, and
N G Miroshnichenko, and
O V Troepol'skaia, and
L V Ivanova, and
A A Ivanov
June 1958,
Revista medica de Chile,
T N Krasnova, and
E M Shilov, and
I E Tareeva, and
N B Gordovskaia, and
O N Lavrova, and
N G Miroshnichenko, and
O V Troepol'skaia, and
L V Ivanova, and
A A Ivanov
March 1987,
Vrachebnoe delo,
